Congenital cytomegalovirus infection is associated with high maternal socio‐economic status and corresponding low maternal cytomegalovirus seropositivity
- 5 March 2014
- journal article
- research article
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (5) , 368-372
Abstract
Aims: Human cytomegalovirus (CMV) is the leading infectious cause of congenital infection in developed countries. Globally, CMV seropositivity has been associated with low socio‐economic status (SES); however, Australian data are lacking. Therefore, we examined the association between SES and CMV seroprevalence in children and pregnant women.Methods: Three groups were examined: 1, a prospective cohort of Australian children aged 0–15 years (n = 220); 2, a clinic‐based sample of pregnant women (n = 778); and 3, a case series of infants and children (n = 219) with symptomatic congenital CMV infection. SES was determined using a postcode‐based score from the Australian Bureau of Statistics.Group 1 was recruited from endocrinology clinics and follow‐up at Prince of Wales Hospital and Children's Hospital at Westmead. Group 2 was recruited at the Royal Hospital for Women. Congenitally infected infants were identified through the Australian Paediatric Surveillance Unit.Results: CMV seroprevalence among all children was 20% (95% confidence interval (CI) 15–25%), and there was no association with SES (P = 0.58). Seroprevalence among pregnant women was 57% (53–60%), and higher rates of CMV seropositivity were associated with lower SES (P < 0.001). More congenital CMV cases were reported in the highest socio‐economic groups (55%) than the lowest (9%) (P < 0.001).Conclusions: A marked socio‐economic gradient in CMV seroprevalence is evident in Australian pregnant women and cases of congenital CMV but not in unselected Australian children. These findings highlight the importance of a community‐wide approach to CMV awareness and the potential for hygienic measures to reduce the burden of congenital CMV in Australia.Keywords
Funding Information
- NH&MRC (510258)
- UNSW
This publication has 24 references indexed in Scilit:
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialThe Lancet, 2011
- Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune PopulationClinical Infectious Diseases, 2009
- Incidence and Risk of Cytomegalovirus Infection during Pregnancy in an Urban Area of Northern ItalyInfectious Diseases in Obstetrics and Gynecology, 2009
- Prevalence and determinants of cytomegalovirus infection in pre‐school childrenJournal of Paediatrics and Child Health, 2009
- Discussion: ‘Abnormal fetal heart rate tracings in patients with thick meconium staining of the amniotic fluid’ by Xu et alAmerican Journal of Obstetrics and Gynecology, 2009
- Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES IIIEpidemiology and Infection, 2008
- National Serosurvey of Cytomegalovirus in AustraliaClinical and Vaccine Immunology, 2006
- Social Inequality: Utilisation of general practitioner services by socio‐economic disadvantage and geographic remotenessAustralian and New Zealand Journal of Public Health, 2004
- Cytomegalovirus prevalence in pregnant women: the influence of parity.Archives of Disease in Childhood, 1992
- Prevalence and importance of congenital cytomegalovirus infection in three different populationsThe Journal of Pediatrics, 1982